Efficacy and safety of tolterodine in people with neurogenic detrusor overactivity.

Abstract

OBJECTIVE To compare tolterodine with oxybutynin and placebo in people with neurogenic detrusor overactivity. DESIGN Prospective, randomized, double-blind, crossover trial plus open-label comparative stage. PARTICIPANTS Ten participants with neurogenic detrusor overactivity due to spinal cord injury or multiple sclerosis who used intermittent… (More)

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.